These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 9313073)

  • 21. SURUSS in perspective.
    Wald NJ; Rodeck C; Hackshaw AK; Rudnicka A
    BJOG; 2004 Jun; 111(6):521-31. PubMed ID: 15198778
    [TBL] [Abstract][Full Text] [Related]  

  • 22. First-trimester screening for trisomy 21 in twin pregnancy: does the addition of biochemistry make an improvement?
    Goncé A; Borrell A; Fortuny A; Casals E; Martínez MA; Mercadé I; Cararach V; Vanrell JA
    Prenat Diagn; 2005 Dec; 25(12):1156-61. PubMed ID: 16231401
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficiency of ultrasound and biochemical markers for Down's syndrome risk screening. A prospective study.
    Benattar C; Audibert F; Taieb J; Ville Y; Roberto A; Lindenbaum A; Frydman R
    Fetal Diagn Ther; 1999; 14(2):112-7. PubMed ID: 10085510
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of first-trimester nuchal translucency on second-trimester maternal serum biochemical screening for Down's syndrome.
    Thilaganathan B; Slack A; Wathen NC
    Ultrasound Obstet Gynecol; 1997 Oct; 10(4):261-4. PubMed ID: 9383877
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Integrated ultrasound and biochemical screening for trisomy 21 using fetal nuchal translucency, absent fetal nasal bone, free beta-hCG and PAPP-A at 11 to 14 weeks.
    Cicero S; Bindra R; Rembouskos G; Spencer K; Nicolaides KH
    Prenat Diagn; 2003 Apr; 23(4):306-10. PubMed ID: 12673635
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sequential screening for trisomy 21 by nuchal translucency measurement in the first trimester and maternal serum biochemistry in the second trimester in a low-risk population.
    Schuchter K; Hafner E; Stangl G; Ogris E; Philipp K
    Ultrasound Obstet Gynecol; 2001 Jul; 18(1):23-5. PubMed ID: 11489220
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prospective evaluation of prenatal maternal serum screening for trisomy 18.
    Yankowitz J; Fulton A; Williamson R; Grant SS; Budelier WT
    Am J Obstet Gynecol; 1998 Mar; 178(3):446-50. PubMed ID: 9539506
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monozygotic twins with trisomy 18 of paternal origin: prenatal diagnosis and molecular cytogenetic characterization in a pregnancy with one structurally abnormal living fetus and one intrauterine fetal demise.
    Chen CP; Chern SR; Chen YY; Wu PC; Town DD; Chen WL; Wang W
    Taiwan J Obstet Gynecol; 2012 Sep; 51(3):430-4. PubMed ID: 23040931
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The comprehensive midtrimester test: high-sensitivity Down syndrome test.
    Bahado-Singh R; Shahabi S; Karaca M; Mahoney MJ; Cole L; Oz UA
    Am J Obstet Gynecol; 2002 Apr; 186(4):803-8. PubMed ID: 11967511
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Screening for Down syndrome using first-trimester ultrasound and second-trimester maternal serum markers in a low-risk population: a prospective longitudinal study.
    Audibert F; Dommergues M; Benattar C; Taieb J; Thalabard JC; Frydman R
    Ultrasound Obstet Gynecol; 2001 Jul; 18(1):26-31. PubMed ID: 11489221
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monozygotic twin discordant for Down syndrome: mos 47,XX,+21/46,XX and 46,XX.
    Choi SA; Ko JM; Shin CH; Yang SW; Choi JS; Oh SK
    Eur J Pediatr; 2013 Aug; 172(8):1117-20. PubMed ID: 23559333
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nuchal translucence incorporated into a one-stage multifactorial screening model for Down syndrome prediction at second-trimester pregnancy.
    Hung JH; Fu CY; Yuan CC; Chen CL; Yang ML; Shu LP; Wu CC
    Ultrasound Med Biol; 2003 Dec; 29(12):1667-74. PubMed ID: 14698332
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased fetal nuchal translucency at 11-14 weeks.
    Nicolaides KH; Heath V; Cicero S
    Prenat Diagn; 2002 Apr; 22(4):308-15. PubMed ID: 11981911
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nuchal translucency thickness and crown-rump length in twin pregnancies with chromosomally abnormal fetuses.
    Pandya PP; Hilbert F; Snijders RJ; Nicolaides KH
    J Ultrasound Med; 1995 Aug; 14(8):565-8. PubMed ID: 7474052
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Non-invasive prenatal screening of fetal Down syndrome by maternal plasma DNA sequencing in twin pregnancies.
    Lau TK; Jiang F; Chan MK; Zhang H; Lo PS; Wang W
    J Matern Fetal Neonatal Med; 2013 Mar; 26(4):434-7. PubMed ID: 23035860
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ultrasonographic markers for chromosomal abnormalities in women with negative nuchal translucency and second trimester maternal serum biochemistry.
    Verdin SM; Whitlow BJ; Lazanakis M; Kadir RA; Chatzipapas I; Economides DL
    Ultrasound Obstet Gynecol; 2000 Oct; 16(5):402-6. PubMed ID: 11169322
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combining nuchal translucency and serum markers in prenatal screening for Down syndrome in twin pregnancies.
    Wald NJ; Rish S; Hackshaw AK
    Prenat Diagn; 2003 Jul; 23(7):588-92. PubMed ID: 12868090
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation of ultrasound findings and biochemical markers in the second trimester of pregnancy in fetuses with trisomy 21.
    Souter VL; Nyberg DA; El-Bastawissi A; Zebelman A; Luthhardt F; Luthy DA
    Prenat Diagn; 2002 Mar; 22(3):175-82. PubMed ID: 11920888
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The influence of fetal sex in screening for trisomy 21 by fetal nuchal translucency, maternal serum free beta-hCG and PAPP-A at 10-14 weeks of gestation.
    Spencer K; Ong CY; Liao AW; Papademetriou D; Nicolaides KH
    Prenat Diagn; 2000 Aug; 20(8):673-5. PubMed ID: 10951481
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Down syndrome: prenatal risk assessment and diagnosis.
    Newberger DS
    Am Fam Physician; 2000 Aug; 62(4):825-32, 837-8. PubMed ID: 10969860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.